Rajagopal, S., & Ray, G. (2017). Carbapenem vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts by Propensity Score. Open Forum Infect Dis.
Citação norma ChicagoRajagopal, Sumanth, and G.Thomas Ray. "Carbapenem Vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts By Propensity Score." Open Forum Infect Dis 2017.
MLA引文Rajagopal, Sumanth, and G.Thomas Ray. "Carbapenem Vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts By Propensity Score." Open Forum Infect Dis 2017.
警告：這些引文格式不一定是100％准確.